Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 4
1991 1
1992 3
1993 5
1994 5
1995 6
1996 9
1997 4
1998 7
1999 9
2000 8
2001 6
2002 8
2003 14
2004 5
2005 5
2006 2
2007 6
2008 15
2009 12
2010 18
2011 11
2012 11
2013 14
2014 9
2015 16
2016 13
2017 13
2018 19
2019 23
2020 26
2021 35
2022 33
2023 29
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Results by year

Filters applied: . Clear all
Page 1
Understanding visual hallucinations: A new synthesis.
Collerton D, Barnes J, Diederich NJ, Dudley R, Ffytche D, Friston K, Goetz CG, Goldman JG, Jardri R, Kulisevsky J, Lewis SJG, Nara S, O'Callaghan C, Onofrj M, Pagonabarraga J, Parr T, Shine JM, Stebbins G, Taylor JP, Tsuda I, Weil RS. Collerton D, et al. Among authors: kulisevsky j. Neurosci Biobehav Rev. 2023 Jul;150:105208. doi: 10.1016/j.neubiorev.2023.105208. Epub 2023 May 2. Neurosci Biobehav Rev. 2023. PMID: 37141962 Free article. Review.
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Litvan I, et al. Among authors: kulisevsky j. Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24. Mov Disord. 2012. PMID: 22275317 Free PMC article. Review.
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. Among authors: kulisevsky j. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force. Goetz CG, et al. Among authors: kulisevsky j. Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340. Mov Disord. 2008. PMID: 19025984
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.
Kulisevsky J, Martínez-Horta S, Campolongo A, Pascual-Sedano B, Marín-Lahoz J, Bejr-Kasem H, Labandeira-Garcia JL, Lanciego JL, Puig-Davi A, Horta-Barba A, Pagonabarraga J, Rodríguez-Antigüedad J. Kulisevsky J, et al. Parkinsonism Relat Disord. 2023 May;110:105367. doi: 10.1016/j.parkreldis.2023.105367. Epub 2023 Mar 21. Parkinsonism Relat Disord. 2023. PMID: 36963339 Clinical Trial. No abstract available.
Apathy in Parkinson's Disease.
Pagonabarraga J, Kulisevsky J. Pagonabarraga J, et al. Among authors: kulisevsky j. Int Rev Neurobiol. 2017;133:657-678. doi: 10.1016/bs.irn.2017.05.025. Epub 2017 Jul 10. Int Rev Neurobiol. 2017. PMID: 28802937 Review.
Mild cognitive impairment in Parkinson's disease.
Martinez-Horta S, Kulisevsky J. Martinez-Horta S, et al. Among authors: kulisevsky j. J Neural Transm (Vienna). 2019 Jul;126(7):897-904. doi: 10.1007/s00702-019-02003-1. Epub 2019 Apr 8. J Neural Transm (Vienna). 2019. PMID: 30963293 Review.
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C. Ferreira JJ, et al. Among authors: kulisevsky j. Mov Disord. 2022 Jan;37(1):25-35. doi: 10.1002/mds.28855. Epub 2021 Nov 29. Mov Disord. 2022. PMID: 34842303 Review.
Apathy: who cares?
Krack P, Pagonabarraga J, Strafella AP, Kulisevsky J. Krack P, et al. Among authors: kulisevsky j. Lancet Neurol. 2015 May;14(5):465. doi: 10.1016/S1474-4422(15)00031-9. Epub 2015 Apr 12. Lancet Neurol. 2015. PMID: 25895927 No abstract available.
374 results